SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?

The global COVID-19 pandemic continues due to emerging Severe Acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC). Here, we performed comprehensive analysis of in-house sequenced SARS-CoV-2 genome mutations dynamics in the patients infected with the VOCs - Delta and Omicr...

Descripción completa

Detalles Bibliográficos
Autores principales: Saifi, Sheeba, Ravi, Varsha, Sharma, Sparsh, Swaminathan, Aparna, Chauhan, Nar Singh, Pandey, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419439/
https://www.ncbi.nlm.nih.gov/pubmed/36041637
http://dx.doi.org/10.1016/j.ygeno.2022.110466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419439/
https://www.ncbi.nlm.nih.gov/pubmed/36041637
http://dx.doi.org/10.1016/j.ygeno.2022.110466

Ejemplares similares